By Craig Clough ( December 13, 2019, 1:54 PM EST) -- A California federal jury awarded Juno Therapeutics and Sloan Kettering $752 million on Friday after finding that Kite Pharma willfully infringed a patent for cancer immunotherapy, bringing a dramatic end to a high-stakes trial that hinged largely on a purported typo....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.